In the rat Alzheimer’s disease model, resveratrol defends BBB integrity by reducing advanced glycation end products (RAGE), matrix metalloprotein-9 (MMP-9) and increasing Claudin-5 but also reduces neuroinflammation by affecting nuclear factor NF-κB expression [63]. Here, CLDN5 is linked to early-onset autosomal dominant Alzheimer disease.